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The authors of the above cited paper [l] remind 
readers that the ‘pancreatic stone protein’ was 
isolated in 1979 from pancreatic stones in patients 
suffering from chronic calcifying pancreatitis [2]. 
This protein was purified and characterized and 
the term of ‘pancreatic stone protein’ was 
associated to a phosphoglycoprotein of 14 kDa 
with an unusual chemical composition containing 
a high (42%) acidic amino acid content, lacking 
methionine and presenting an AsX as N-terminal 
residue [3]. These molecular characteristics imilar 
to those of inhibitors of crystal nucleation and 
growth found in saliva and in urine apparently ex- 
plained the putative role of the protein in in- 
hibiting in vivo the CaCOJ-crystal growth in 
pancreatic juice and therefore preventing stone 
formation [3]. 
In 1986 the same authors [4] published the par- 
tial amino acid sequence of ‘pancreatic stone pro- 
tein’ but this protein was clearly different from 
that previously characterized. It was no more a 
phosphoglycoprotein but a protein apparently 
devoid of sugars and presenting an amino acid 
composition completely different from the first 
pancreatic stone protein. This new amino acid 
composition closely corresponded to that of a 
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degradation product of the same molecular mass 
that we had isolated from human pancreatic juice 
in 1984 and called protein X [5]. Moreover the first 
15 N-terminal residues of this novel stone protein 
were identical to those we published for protein X 
(except for 3 missing amino acids in our sequence), 
and to those reported in 1985 for a protein isolated 
from human pancreas by Gross et al. [6]. In the 
same paper [5] we showed that the 14 kDa protein 
was generated by proteolysis of a family of 19 kDa 
precursors which could be isolated from human 
pancreatic juice when the purification experiments 
were performed in the presence of additional pro- 
teinase inhibitors. We realized the proteolytic con- 
version of the precursors into protein X by using 
chymotrypsin which demonstrated that the 14 kDa 
protein was not secreted as such by human pan- 
creas as claimed later by Giorgi et al. [7]. 
No reference to our previous data was mention- 
ed in the paper of Rouimi et al. [l] who confirmed 
that the 14 kDa protein was generated by pro- 
teolysis (tryptic instead of chymotryptic) from 
precursors of higher molecular mass. These 
precursors remain to be identified, they are ap- 
parently not structurally related to trypsinogen 1 
despite the immunological relationship found with 
denatured zymogen [5,8]. 
The now clear evidence that the 14 kDa protein 
found in pancreatic stones [l] and activated pan- 
creatic juice [5] was not a native secretory protein 
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but a proteolysis product having a strong tendency 
to precipitate at pH 8.0 [6], gave support to our 
previous hypothesis of a pathogenic role for the 
premature zymogen activation of over-stimulated 
acinar cells in pancreatitis [9, lo]. 
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1. P. ROUIMI, J. BONICEL AND 
M. ROVERY’S ANSWER 
First we would like to specify that our research 
group in the Centre de Biochimie et de Biologie 
Moleculaire, CNRS, Marseille, had nothing to do 
with the misunderstandings by several members of 
the same team which led to its breaking up in 198 1. 
In 1985, Professor H. Sarles and Dr A. De Caro 
asked us to collaborate in the determination of the 
primary structure of the human pancreatic stone 
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protein prepared from calculi (PSP) as well as of 
its immunoreactive forms from the pancreatic 
juice (PSP Sl-5). Our research group is indeed 
equipped for protein sequencing and trained in 
structural determination methods. Having worked 
for several years on pancreas proteolytic enzyme 
precursors, their activation, their proteolyses, the 
proposed research was of great interest to us and 
fitted into the frame of our research field. 
Together with Dr A. De Caro we endeavoured a 
thorough study of the various PSP forms. 
In the first report [l] written in collaboration, 
our contribution dealt with amino acid composi- 
tions and N-terminal sequence determinations of 
the 40 and 65 first amino acids of PSP and PSP Sl , 
respectively. At that time we mentioned the report 
of Dr Figarella’s group [2] since the 15 first amino 
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